RAC1 and neoplasm: Beyond the 4% of melanoma cases with mutant RAC1, it is also worth speculating whether RAC signaling pathways may be activated in melanoma and perhaps other tumor types by different mechanisms, such as alterations in upstream regulatory proteins such as PREX and TIAM1.